BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arrow Financial, ImmunityBio, Seagate, and Baxter and Encourages Investors to Contact the Firm
July 21, 2023 21:00 ET | Bragar Eagel & Squire
NEW YORK, July 21, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arrow Financial, ImmunityBio, Seagate, and Baxter and Encourages Investors to Contact the Firm
July 16, 2023 20:58 ET | Bragar Eagel & Squire
NEW YORK, July 16, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
GRIZ_CorzaMedical-Full Logo-Color.png
Corza Medical Announces Direct Distribution of TachoSil® to the US Market
April 20, 2023 09:05 ET | Corza Medical Inc.
WESTWOOD, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Corza Medical (“Corza”) announced strategic plans to directly sell TachoSil®, a best-in-class surgical fibrin sealant patch trusted by medical...
BES_Mark.jpg
HILL-ROM ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of HRC and Encourages Investors to Contact the Firm
September 03, 2021 12:04 ET | Bragar Eagel & Squire
NEW YORK, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or...
DEADLINE ALERT for DOMO, AFI, CGC, and BAX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
December 09, 2019 11:00 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation on Behalf of Baxter International Inc. Investors
November 05, 2019 12:17 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors...
Unknown.png
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
February 05, 2019 07:50 ET | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
Unknown.png
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
December 20, 2018 07:50 ET | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
Unknown.png
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
December 17, 2018 07:50 ET | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Unknown.png
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
December 06, 2018 07:50 ET | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...